It Is High Time: Rationale for Inclusion of Quantitative Markers for Acute Mountain Sickness Screening

Luks AM , Beidleman BA , Freer L , et al. Wilderness medical society clinical practice guidelines for the prevention, diagnosis, and treatment of acute altitude illness: 2024 Update. Wilderness Environ Med, 2024; 35(1_Suppl):2S–19S.

Pham K , Parikh K , Heinrich EC . Hypoxia and inflammation: Insights from high-altitude physiology. Front Physiol, 2021; 12:676782.

Roach RC , Hackett PH , Oelz O , et al. Lake Louise AMS Score Consensus Committee. The 2018 lake louise acute mountain sickness score. High Alt Med Biol, 2018; 19(1):4–6. Lake Louise AMS Score Consensus Committee.

Wu J , Gu H , Luo Y . Differences between the “Chinese AMS Score” and the lake louise score in the diagnosis of acute mountain sickness. Medicine (Baltimore), 2016; 95(21):e3512.

Yang J , Jia Z , Song X , et al. Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort. Commun Biol, 2022; 5(1):548.